Canaccord Genuity Maintains a 'Buy' on MAP Pharmaceuticals (MAPP); Q1 EPS A Non-event; Focus Remains on LEVADEX

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BABA
9. DE
10. NTES

Go back to Canaccord Genuity Maintains a 'Buy' on MAP Pharmaceuticals (MAPP); Q1 EPS A Non-event; Focus Remains on LEVADEX
MAP Pharmaceuticals, Inc. (NYSE: MAPP) Delayed: 28.16 +0.18 (0.64%)
Previous Close $27.98    52 Week High $25.03 
Open $28.16    52 Week Low $11.11 
Day High $28.16    P/E N/A 
Day Low $28.16    EPS $-3.11 
Volume 55